Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

Project description

Measuring cell plasticity as an indicator of cancer aggressiveness

Cellular identity may change and become plastic during development or under perturbation of homeostasis as in cancer. Our understanding of the process of cell plasticity in its native context has been hampered by the lack of assays that can capture the associated phenotypic changes at the single cell level. To overcome this limitation, the EU-funded PLAST_CELL project proposes to develop a microfluidics platform capable of measuring morphometric and molecular data in live cells. The platform will combine super-resolution microscopy with dynamic imaging and offers a way to quantify tumour cell plasticity and predict aggressiveness, providing a valuable tool for disease management and therapy.

Objective

Metastasis is the major cause of death in cancer patients due to cancer cell dissemination to distant organs. Cell plasticity is a core characteristic of metastatic cells and confers cellular adaptation capabilities to variable mechano-chemical tissue microenvironments. However, to date, specific quantitative measures of cancer cell plasticity associated with tumour aggressiveness and therapy resistance have remained difficult to establish. A major limitation is the availability of highthroughput multiplexed assays that can capture phenotypic heterogeneity and morphodynamic plasticity at the single cell level in standardized 3D culture conditions reflecting in vivo tissue microenvironments. The PLAST_CELL interdisciplinary consortium will pioneer the development of a microfluidics-based imaging platform to categorize and score cancer cell plasticity within diverse physiologically relevant 3D biomimetic culture conditions. The platform will enable to perform single cell multi-scale morphometric and molecular live cell data collection (PLAST_DATA) with minimal sample size (<10k cells). Data will be generated based on single molecule-sensitivity marker detection and cellular/subcellular morphodynamic feature recognition via minimal-invasive long-term super-resolution microscopy and parallel morphodynamic imaging of cellular behaviour. Computational integration of PLAST_DATA using preclinical models and patient samples will enable to develop a quantitative classification of tumour cell plasticity and predictive scoring of cancer aggressiveness, metastasis and drug resistance (PLAST_SCORE). The ability to assess cell plasticity based on cellular behaviours is beyond current clinical parameters and will strongly impact diagnosis, prognosis and treatments. The PLAST_CELL platform will be a technology breakthrough to establish new quantitative standards to evaluate cell plasticity and mechanisms of tumour malignancy for a new era of basic research and personalized medicine.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-EIC - HORIZON EIC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIC-2021-PATHFINDEROPEN-01

See all projects funded under this call

Coordinator

FUNDACIO CENTRE DE REGULACIO GENOMICA
Net EU contribution
€ 1 063 091,00
Address
CARRER DOCTOR AIGUADER 88
08003 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
€ 1 063 091,00

Participants (5)